Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens - Wikidata - awgldk - TriplyDB

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

http://www.wikidata.org/entity/Q33767097

about

Early detection of sensorineural hearing loss in Muckle-Wells-syndrome A case of cryopyrin-associated periodic syndrome with kidney transplant failure.Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives An expanding role for interleukin-1 blockade from gout to cancer.The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome.Treating inflammation by blocking interleukin-1 in humans.Anakinra for cryopyrin-associated periodic syndrome.Recommendations for the management of autoinflammatory diseases.Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.Pharmacological treatment options for cryopyrin-associated periodic syndromes.Effects of Anakinra on Health-Related Quality of Life in a Patient with 1129G>A/928G>A Mutations in MVK Gene and Heterozygosity for the Mutation 2107C>A in CIAS1 Gene.Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.Overview of the IL-1 family in innate inflammation and acquired immunity.Resolution of unilateral sensorineural hearing loss in a pediatric patient with a severe phenotype of Muckle-Wells syndrome treated with Anakinra: a case report and review of the literature.Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study.Anakinra Therapy for Non-cancer Inflammatory Diseases

P2860

Q27303524-B34E7528-73D5-472B-B54A-8DA312DDF5C3 Q33622218-6B3A9E83-79C7-4CBD-938C-D267FA113004 Q35133812-D24EEB48-8FAF-4791-A3EB-FF0957DA074B Q35219001-2BFF6D56-A2B4-4055-92E7-843C0F4B0FCB Q35879125-41814E76-4033-446F-94AA-7400312478C2 Q37636664-0A80ED9F-1758-415C-B4D1-4DB8DC6E5417 Q38168948-4DFB7173-7D78-410B-BC3A-99659224A0F4 Q38537504-C60D78A6-C377-4567-B615-321F568ADD2A Q38574807-9D80BCD1-F2A1-4D0E-9F88-823E900062C3 Q38674213-07A0BEDA-3D40-462E-B56C-B1629179B497 Q40051587-FD21C5F8-1A13-4A6B-B158-026B5CA1205A Q40154874-126A4E55-7E85-401B-9375-69B409A3C174 Q47285878-343E05EE-027C-423E-A0D0-412ABA4C5F59 Q49574128-CF4727E2-E281-439A-B2F2-F56CE0D3486A Q54945833-DFAE46B0-6E3C-470E-8129-F77B69DF35BE Q59136398-AA20F23C-FF39-49B7-850B-6A6475809085

P2860

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

http://www.wikidata.org/entity/Q33767097

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

@ast

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

@en

type

label

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

@ast

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

@en

prefLabel

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

@ast

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

@en

P1433

Q33767097-FBA97DB0-4762-443F-9BA5-A1922E64856F

P1476

Q33767097-384EAA2E-3BCD-41FC-A2A5-0B4C0A89BB7A

P2093

Q33767097-026DBDED-A0DF-4161-9CB5-471590FE2EF8

Q33767097-28054E91-37B6-4B0D-AF23-793DDD34FE3F

Q33767097-3A3C6217-EC85-4A55-B392-564B1ABFBB27

Q33767097-55DAE161-2727-43E4-B4AF-902220581965

Q33767097-7D9F2F7C-65EF-4BA2-914B-12DADE1A1081

Q33767097-95A3BD54-9098-4550-B332-D75B26FDFBA4

Q33767097-99C1231F-FEAF-4CC9-B0A2-088AFC7BAEB7

Q33767097-9E652966-6EB4-4C86-9E78-87387ACE6164

Q33767097-A25548F5-865B-462E-B1D7-289533ABF86D

Q33767097-B2A64624-B08A-4809-B063-CA401B4494DA

P2860

Q33767097-01D6A4AC-2170-49B7-B83A-20EA53CEFB2A

Q33767097-07061DE3-411F-47BD-BC47-46C4E54AB906

Q33767097-0C72ED1D-2605-4299-AA36-2F948437E4A0

Q33767097-0E43E6A1-55F3-41D6-874B-BC89C16DE2FA

Q33767097-20CC6DDA-C900-4C61-9115-277ED97982F8

Q33767097-2BFA0896-4584-4CEE-BA2A-E17DF1AABBD1

Q33767097-31759B97-C7EA-4EEC-BE14-8C8DF3FB853E

Q33767097-36629EE5-0332-4E77-AFAB-ACC4DB0B0DF6

Q33767097-3ECC4E4B-1078-406E-8EA8-E2BF38FD7792

Q33767097-45ABBD06-D3E4-412C-9427-F1E545406CA7

P2888

Q33767097-7039B998-9EC1-46DB-9515-2B62255D6BD4

P304

Q33767097-0B567097-5932-4DC8-998B-048D593C116D

P31

Q33767097-227E4205-4576-444C-A2B1-A4ABB378E2CC

P356

Q33767097-61ABBB07-D44D-4776-A8E6-C95BCDC80322

P433

Q33767097-E6486F5E-A5B1-40E3-8BCF-5F58C901BE6C

P478

Q33767097-12700FC6-CDE7-4F5A-A850-F9361D80AD75

P50

Q33767097-B4B3C9BD-A8C7-41B8-8E92-7F97AF7F9981

P577

Q33767097-07A2E2AA-CB57-48A7-AC58-CBF1FC77DBBC

P5875

Q33767097-D254537E-17BB-4C58-98B4-B84707CD1C62

P698

Q33767097-9C8E5D42-38EB-471A-9DA5-23EC1B88D7E6

P932

Q33767097-97DFD402-3722-4FDA-8B14-42EE7DA2B548

P356

P1433

Arthritis Research and Therapy

P1476

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens

@en

P2093

Anja Bialkowski

http://www.w3.org/2001/XMLSchema#string

Assen Koitschev

http://www.w3.org/2001/XMLSchema#string

Christoph Deuter

http://www.w3.org/2001/XMLSchema#string

Dirk Foell

http://www.w3.org/2001/XMLSchema#string

Fabian Reess

http://www.w3.org/2001/XMLSchema#string

Helmut Wittkowski

http://www.w3.org/2001/XMLSchema#string

Ina Koetter

http://www.w3.org/2001/XMLSchema#string

Jasmin B Kuemmerle-Deschner

http://www.w3.org/2001/XMLSchema#string

Katharina Ummenhofer

http://www.w3.org/2001/XMLSchema#string

Peter Lohse

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease

Gout-associated uric acid crystals activate the NALP3 inflammasome

Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome

Familial autoinflammatory diseases: genetics, pathogenesis and treatment

Cryopyrin activates the inflammasome in response to toxins and ATP

Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1

P2888

P304

R64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR4237

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Pascal N. Tyrrell

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236966876

http://www.w3.org/2001/XMLSchema#string

P698

23718630

http://www.w3.org/2001/XMLSchema#string

P932

4060562

http://www.w3.org/2001/XMLSchema#string